A strategic buyer is offering a high valuation based on a multiple of our revenue, while a private equity firm is offering a lower multiple based on our EBITDA. How do we evaluate these two competing valuation methodologies without getting burned by integration risks?

Question

Tyler Smith · Accepted Answer

A strategic buyer pays a revenue-based multiple because they expect to eliminate your back-office costs and integrate your product into their existing distribution channel. This looks highly attractive on paper, but it usually comes with complex integration plans and high execution risk. A private equity buyer pays an EBITDA multiple because they want to use your business as a platform, meaning you will likely remain operationally independent but with a lower upfront valuation. To evaluate these offers, you must look beyond the headline number and evaluate the post-close operating reality. Use your V/TO to assess whether your long-term vision aligns with the strategic buyer's integration timeline. If their transition plan requires your team to immediately migrate to their systems, it could disrupt your operations and kill your culture, put your customer retention at risk, and jeopardize any rolled-over equity. Conversely, a platform buy by a private equity sponsor might allow you to keep your leadership team and Accountability Chart fully intact. You must run a sensitivity analysis on both deal structures. A slightly lower EBITDA multiple with clean post-close autonomy and low integration risk can often yield a higher net wealth outcome than a high revenue multiple that is chained to unrealistic synergy targets and operational chaos.